FLGT Q1 2017 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q1 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M+54.2% YoY

Gross Profit

$3M65.0% margin

Operating Income

$219,0004.1% margin

Net Income

$232,0004.4% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-9.4%

Cash Flow

Operating Cash Flow

$707,000

Free Cash Flow

$617,000

Stock-Based Comp.

$565,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$4M

Stockholders' Equity

$55M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+54.2%
Gross Profit	$3M	$2M	+61.4%
Operating Income	$219,000	-$615,000	+135.6%
Net Income	$232,000	-$543,000	+142.7%

Geographic Segments

UNITED STATES

$2M39%

CHINA

$2M29%

CANADA

$1M20%

Other Countries

$608,00011%